Why Patients Stop
GLP-1 Medications
Up to 75% of patients quit within 12 months — before experiencing the full benefit. This 8-chapter evidence-based ebook reveals every driver of discontinuation and gives you the blueprint to stay on track.
8 Chapters. Every Driver Covered.
From biology to psychology to systemic barriers — this ebook gives you the full picture and actionable solutions for each one.
Why 50–75% quit within 12 months, what happens physiologically when you stop, and the real cost of the gap between stopping and restarting.
Nausea, constipation, fatigue, GERD, hair thinning, muscle loss — what causes each, when they resolve, and how to manage them without quitting.
$1,349/month sticker shock, near-100% prior auth requirements, denial rates, and practical strategies to appeal, appeal again, and find coverage.
The "I should do this naturally" stigma, fear of long-term effects, identity disruption, and social pressure — and the evidence-based reframes that help.
Plateau frustration, unrealistic expectations set by social media, scale obsession, and how to track the metrics that matter beyond weight.
Supply chain shortages, the compounding ban aftermath, pharmacy gaps — and how to plan around availability disruptions without losing momentum.
Why the medication alone isn't enough — and the protein targets, resistance training protocols, and accountability structures that maximize results.
6 evidence-based strategies — slow titration, protein-first eating, hydration, resistance training, multi-metric tracking, and behavioral support — proven to keep you on track.
This Guide Was Written For You If…
Don't Let a Solvable Problem
End Your Progress
Every driver of GLP-1 discontinuation has a known solution. This ebook gives you the evidence, the tools, and the blueprint to stay on your medication — and get the outcomes you started for.
For educational purposes only. Not medical advice. Consult your healthcare provider before making any treatment changes.